Blue Therapeutics announces Series A raise

Unveiling disruptive IND stage receptor-interactomicsTM platform and pipeline WALTHAM, Mass., April 30, 2021 -- (Healthcare Sales & Marketing Network) -- Blue Therapeutics is a Boston based drug discovery and development company. The lead asset BLUE-18... Biopharmaceuticals, Venture Capital Blue Therapeutics, receptor-interactomics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news